The Landscape Is Specific
AI in healthcare generates enormous interest and genuine promise. Clinical decision support, administrative automation, diagnostic assistance, patient communication — the potential applications are real, and the pressure to deploy is intensifying as health systems face workforce shortages and growing demand.
The compliance environment in Canadian healthcare, however, is specific in ways that many AI vendors have not accounted for. Organisations that deploy AI without understanding the privacy and data governance landscape are not just taking on legal risk — they are building systems that will need to be substantially redesigned when the compliance requirements become clear. That redesign is expensive, disruptive, and, in the worst cases, leads to systems being decommissioned after significant investment.
Getting the privacy framework right before building is not overcaution. It is what makes the building sustainable.
The Multi-Layered Legislative Context
Canadian healthcare privacy is not governed by a single statute. It is governed by an overlapping set of federal and provincial frameworks that interact in ways that require careful mapping for each specific deployment context.
PIPEDA — the Personal Information Protection and Electronic Documents Act — establishes the federal baseline for private sector handling of personal information, including health information. But healthcare in Canada is primarily regulated provincially, and most provinces have their own health information legislation that supersedes PIPEDA in the provincial health sector.
Ontario has the Personal Health Information Protection Act (PHIPA). Alberta has the Health Information Act (HIA). British Columbia has the E-Health (Personal Health Information Access and Protection of Privacy) Act. Each statute has specific requirements around collection, use, disclosure, and custody of personal health information that differ in important ways from PIPEDA and from each other.
For federal health institutions — Veterans Affairs, First Nations health services, certain federal correctional health services — the Privacy Act governs, not PIPEDA.
An AI vendor who tells you their system is "PIPEDA-compliant" is telling you something that may be true and is simultaneously insufficient. PIPEDA compliance is a floor, not a ceiling, for most Canadian healthcare deployments. The relevant question is whether the system meets the requirements of the specific provincial or federal legislation that applies to your organisation and your data.
What AI Systems Must Address
The specific requirements that matter for AI system design in healthcare are not abstract privacy principles — they are operational design decisions.
Data residency and sovereignty. Provincial health information legislation generally requires that personal health information be stored and processed within Canada, and in some cases within the province. AI systems that process health data through servers located in the United States — or through cloud infrastructure that could route data outside Canada — are not compliant with these requirements regardless of contractual protections. Cloud infrastructure must be explicitly Canadian, with Canadian data centres and contractual guarantees that data does not leave those facilities.
This immediately narrows the AI vendor landscape. Many major AI platforms default to US-based infrastructure. Canadian healthcare organisations need to verify, contractually and technically, that their specific deployment configuration keeps data within the required jurisdiction.
Consent and purpose limitation. Health information is collected for specific purposes — clinical care, administration, public health — and legislation limits secondary uses. Using clinical data to train or fine-tune an AI model is a secondary use that may require specific consent or legislative authority depending on the province and the nature of the data. Organisations that assume they can use existing health records to train custom AI models without consent or authority are creating significant legal exposure.
The purpose limitation issue affects more than training. It affects inference. A system that generates insights or predictions from health information needs a lawful basis for that use. The fact that the insights might be clinically useful does not automatically constitute a lawful basis under provincial health information legislation.
Custody and access controls. Healthcare organisations are generally required to maintain custody and control of personal health information. Systems where a vendor has access to identifiable health data — whether through model training, system administration, or data pipeline design — need specific contractual and technical protections. Data processing agreements need to specify that the vendor cannot use health data for any purpose other than the specified service, cannot share data with subprocessors without authorisation, and is subject to audit.
Practical Design Principles for Compliant Healthcare AI
Compliance requirements in Canadian healthcare do not prevent AI deployment. They shape it.
De-identification before AI processing where possible. Many AI use cases in healthcare do not require identifiable data. Administrative automation, scheduling optimisation, resource allocation, and research applications often work on aggregated or de-identified data. Designing systems to operate on the minimum identifiable data necessary — and to process identifiable data only where specifically required for the clinical purpose — reduces compliance burden and limits risk.
De-identification must meet the relevant legislative standard. Provincial health information legislation often specifies what constitutes adequate de-identification. "Removing the name and health card number" does not meet the standard for data that retains sufficient detail to be re-identifiable.
Privacy impact assessments before deployment. A Privacy Impact Assessment (PIA) is not a bureaucratic exercise — it is a structured analysis of how a system collects, uses, stores, and discloses personal health information, and what controls are required. Most provincial health information legislation requires PIAs for new systems or significant changes. Some require submission to the provincial Information and Privacy Commissioner.
Conducting a PIA after a system is built is significantly harder than conducting one during design, because the design decisions that affect privacy are made during architecture and development. The right time for a PIA is before significant development work begins.
Clinical governance alongside technical governance. AI systems in clinical settings — even systems that are primarily administrative — affect clinical workflows and patient care. Clinical governance, which means engagement with clinical leadership on how the system affects practice, is not the same as privacy governance. Both are required. Organisations that treat AI governance as a purely technical and legal function, without engaging clinical and operational leadership, build systems that may be technically compliant but are operationally misaligned.
The Vendor Selection Question
Healthcare organisations evaluating AI vendors need to ask specific questions, not accept general assurances.
Where is data processed and stored? What is the specific infrastructure, in which jurisdiction, with what contractual protections against data leaving that jurisdiction?
Has the vendor conducted a privacy legal analysis against the specific legislation that applies to this organisation? PIPEDA familiarity is not sufficient.
What are the vendor's obligations regarding data use? Can they use client data to train or improve their models? If so, on what basis, and is that basis compatible with the organisation's legal obligations?
What breach notification procedures are in place? Under what timeline and by what process would the vendor notify the organisation of a security incident involving health data?
These are not adversarial questions. They are due diligence questions that any responsible vendor should be able to answer. Vendors who cannot answer them specifically should not be handling personal health information.
The Payoff of Getting It Right
The organisations that invest in getting the privacy framework right before deploying AI are not slower to adopt AI — they are more confident and more sustainable in their adoption. They do not spend time unwinding deployments that failed privacy review. They do not face regulatory scrutiny that requires system redesign. They build AI capability on a foundation that can scale.
Privacy-first AI in healthcare is not a constraint. It is the condition under which AI in healthcare becomes genuinely viable.